BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34943986)

  • 1. Transcriptome Analysis of Induced Pluripotent Stem Cells and Neuronal Progenitor Cells, Derived from Discordant Monozygotic Twins with Parkinson's Disease.
    Vlasov IN; Alieva AK; Novosadova EV; Arsenyeva EL; Rosinskaya AV; Partevian SA; Grivennikov IA; Shadrina MI
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation and characterization of human-derived iPSC lines from three pairs of monozygotic twins discordant for Parkinson's disease.
    Dulovic-Mahlow M; Lukomska A; Diaw SH; Balck A; Borsche M; Grütz K; Lenz I; Rudolph F; Lohmann K; Klein C; Seibler P
    Stem Cell Res; 2019 Dec; 41():101629. PubMed ID: 31706098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptome Profiling Reveals Differential Expression of Circadian Behavior Genes in Peripheral Blood of Monozygotic Twins Discordant for Parkinson's Disease.
    Semenova EI; Vlasov IN; Partevian SA; Rosinskaya AV; Rybolovlev IN; Slominsky PA; Shadrina MI; Alieva AK
    Cells; 2022 Aug; 11(16):. PubMed ID: 36010675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole-Transcriptome Analysis of Dermal Fibroblasts, Derived from Three Pairs of Monozygotic Twins, Discordant for Parkinson's Disease.
    Alieva AK; Rudenok MM; Novosadova EV; Vlasov IN; Arsenyeva EL; Rosinskaya AV; Grivennikov IA; Slominsky PA; Shadrina MI
    J Mol Neurosci; 2020 Feb; 70(2):284-293. PubMed ID: 31823283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.
    Woodard CM; Campos BA; Kuo SH; Nirenberg MJ; Nestor MW; Zimmer M; Mosharov EV; Sulzer D; Zhou H; Paull D; Clark L; Schadt EE; Sardi SP; Rubin L; Eggan K; Brock M; Lipnick S; Rao M; Chang S; Li A; Noggle SA
    Cell Rep; 2014 Nov; 9(4):1173-82. PubMed ID: 25456120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher vulnerability and stress sensitivity of neuronal precursor cells carrying an alpha-synuclein gene triplication.
    Flierl A; Oliveira LM; Falomir-Lockhart LJ; Mak SK; Hesley J; Soldner F; Arndt-Jovin DJ; Jaenisch R; Langston JW; Jovin TM; Schüle B
    PLoS One; 2014; 9(11):e112413. PubMed ID: 25390032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-Cell Sequencing of iPSC-Dopamine Neurons Reconstructs Disease Progression and Identifies HDAC4 as a Regulator of Parkinson Cell Phenotypes.
    Lang C; Campbell KR; Ryan BJ; Carling P; Attar M; Vowles J; Perestenko OV; Bowden R; Baig F; Kasten M; Hu MT; Cowley SA; Webber C; Wade-Martins R
    Cell Stem Cell; 2019 Jan; 24(1):93-106.e6. PubMed ID: 30503143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomics analysis of human iPSC-derived dopaminergic neurons reveals a novel model for sporadic Parkinson's disease.
    Krauskopf J; Eggermont K; Madeiro Da Costa RF; Bohler S; Hauser D; Caiment F; de Kok TM; Verfaillie C; Kleinjans JC
    Mol Psychiatry; 2022 Oct; 27(10):4355-4367. PubMed ID: 35725899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
    Sandor C; Robertson P; Lang C; Heger A; Booth H; Vowles J; Witty L; Bowden R; Hu M; Cowley SA; Wade-Martins R; Webber C
    Hum Mol Genet; 2017 Feb; 26(3):552-566. PubMed ID: 28096185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single-Cell Transcriptomics of Parkinson's Disease Human In Vitro Models Reveals Dopamine Neuron-Specific Stress Responses.
    Fernandes HJR; Patikas N; Foskolou S; Field SF; Park JE; Byrne ML; Bassett AR; Metzakopian E
    Cell Rep; 2020 Oct; 33(2):108263. PubMed ID: 33053338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Features Underlying Neurodegeneration Identified through In Vitro Modeling of Genetically Diverse Parkinson's Disease Patients.
    Lin L; Göke J; Cukuroglu E; Dranias MR; VanDongen AM; Stanton LW
    Cell Rep; 2016 Jun; 15(11):2411-26. PubMed ID: 27264186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21.
    Hibaoui Y; Grad I; Letourneau A; Sailani MR; Dahoun S; Santoni FA; Gimelli S; Guipponi M; Pelte MF; Béna F; Antonarakis SE; Feki A
    EMBO Mol Med; 2014 Feb; 6(2):259-77. PubMed ID: 24375627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induced Pluripotent Stem Cell-Derived Dopaminergic Neurons from Familial Parkinson's Disease Patients Display α-Synuclein Pathology and Abnormal Mitochondrial Morphology.
    Diao X; Wang F; Becerra-Calixto A; Soto C; Mukherjee A
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic risk for Parkinson's disease correlates with alterations in neuronal manganese sensitivity between two human subjects.
    Aboud AA; Tidball AM; Kumar KK; Neely MD; Ess KC; Erikson KM; Bowman AB
    Neurotoxicology; 2012 Dec; 33(6):1443-1449. PubMed ID: 23099318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive genomic signature of neural and intestinal organoids from familial Parkinson's disease patient-derived induced pluripotent stem cells.
    Son MY; Sim H; Son YS; Jung KB; Lee MO; Oh JH; Chung SK; Jung CR; Kim J
    Neuropathol Appl Neurobiol; 2017 Dec; 43(7):584-603. PubMed ID: 28235153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Embryonic Gene Transcription in Neural Precursor Cells Derived from the Induced Pluripotent Stem Cells of the Patients with Parkinson's Disease.
    Fedoseyeva VB; Novosadova EV; Nenasheva VV; Novosadova LV; Grivennikov IA; Tarantul VZ
    Biochemistry (Mosc); 2023 Apr; 88(4):515-525. PubMed ID: 37080937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case-control study of twin pairs discordant for Parkinson's disease: a search for environmental risk factors.
    Bharucha NE; Stokes L; Schoenberg BS; Ward C; Ince S; Nutt JG; Eldridge R; Calne DB; Mantel N; Duvoisin R
    Neurology; 1986 Feb; 36(2):284-8. PubMed ID: 3945402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating miRNome profiling in Moyamoya disease-discordant monozygotic twins and endothelial microRNA expression analysis using iPS cell line.
    Uchino H; Ito M; Kazumata K; Hama Y; Hamauchi S; Terasaka S; Sasaki H; Houkin K
    BMC Med Genomics; 2018 Aug; 11(1):72. PubMed ID: 30157848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenome-wide DNA methylation analysis in siblings and monozygotic twins discordant for sporadic Parkinson's disease revealed different epigenetic patterns in peripheral blood mononuclear cells.
    Kaut O; Schmitt I; Tost J; Busato F; Liu Y; Hofmann P; Witt SH; Rietschel M; Fröhlich H; Wüllner U
    Neurogenetics; 2017 Jan; 18(1):7-22. PubMed ID: 27709425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant epigenome in iPSC-derived dopaminergic neurons from Parkinson's disease patients.
    Fernández-Santiago R; Carballo-Carbajal I; Castellano G; Torrent R; Richaud Y; Sánchez-Danés A; Vilarrasa-Blasi R; Sánchez-Pla A; Mosquera JL; Soriano J; López-Barneo J; Canals JM; Alberch J; Raya Á; Vila M; Consiglio A; Martín-Subero JI; Ezquerra M; Tolosa E
    EMBO Mol Med; 2015 Dec; 7(12):1529-46. PubMed ID: 26516212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.